The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012
ISRN Hepatology · 2013
DOI: 10.1155/2013/702167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ISRN Hepatology, 2013. Verfasst von Daniela Macedo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Division, Hospital de Santa Maria, Lisbon, Portugal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Neuroendocrine tumors (NETs) comprise a heterogeneous group of tumors that form a distinct entity. Approximately 75–80% of patients present with liver metastases at the time of their diagnosis, and 20%–25% will develop these lesions in the course of their disease. The presence of secondary deposits in the liver significantly increases the morbidity and mortality in these patients. The only potentially curative treatment is the surgical resection of the primary tumor and hepatic lesions. However, only 10% of patients presents under ideal conditions for that approach. Several techniques aimed at localized liver lesions have been applied also with interesting results in terms of survival and symptom control. The same has been demonstrated with new systemic therapies (target therapies). However, these are still under study, in order to define their true role in the management of these patients. This paper intends to address, in a general way, the various treatment options in patients with liver metastases from neuroendocrine tumors.
Autor:innen und Institutionen
- Oncology Division, Hospital de Santa Maria, Lisbon, Portugal.
- Oncology Division, Hospital de Santa Maria, Lisbon, Portugal; Instituto de Medicina Molecular, University of Lisbon, Portugal.
- Radiology Division, Hospital de Santa Maria, Lisbon AV Professor Egas Moniz, 1649-039 Lisbon, Portugal.
ORCID-Profile: Daniela Macedo
Zitieren
APA
Macedo, D., Amaral, T., Fernandes, I., Sousa, A. R., Costa, A. L., Távora, I., Quintela, A., Cortes, P., & Costa, L. (2013). The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012. ISRN Hepatology. https://doi.org/10.1155/2013/702167
Vancouver
Macedo D, Amaral T, Fernandes I, Sousa AR, Costa AL, Távora I, et al. The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012. ISRN Hepatology. 2013. doi:10.1155/2013/702167
BibTeX
@article{Macedo2013,
author = {Macedo, Daniela and Amaral, Teresa and Fernandes, Isabel and Sousa, Ana Rita and Costa, Ana Lúcia and Távora, Isabel and Quintela, António and Cortes, Paulo and Costa, Luís},
title = {The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012},
journal = {ISRN Hepatology},
year = {2013},
doi = {10.1155/2013/702167}
}
EUVIMED